|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
CELL SIGNALING, TRANSCRIPTION AND TRANSLATION AS THERAPEUTIC TARGETS | ||||||||||||||||
May 03, 2001 | ||||||||||||||||
RSL, European Conference Center, Luxembourg Wednesday, January 30 to Saturday, February 2nd 2002 M A I N T O P I C S Session 1 : Protein Domains Session 2 : Bioinformatics in signal transduction and gene expression Session 3 : Integrin signalling Session 4 : Signal transduction in Health and disease Session 5 : Signal Transduction and Inflammation Session 6 : Signaling pathways Session 7 : Nutrients regulated gene expression Session 8 : Apoptosis pathways I Session 9 : Apoptosis pathways II Session 10 : Cell cycle control Session 11 : G proteins Session 12 : Kinase cascades as therapeutic targets Session 13 : Transcription factor paradigms Session 14 : Translational control |
||||||||||||||||
Organized by: | Marc Diederich | |||||||||||||||
Invited Speakers: | Session 1 : Protein Domains - Tony Pawson (Mont Sinai Medical Center, Toronto, Canada) - Michel Véron (CNRS URA 1773 Institut Pasteur, Paris, France) - Joseph Schlessinger (Department of Pharmacology, New York, USA) Szession 2 : Bioinformatics in signal transduction and gene expression - Michael Yaffe (Harvard Medical School, Boston, USA) - Greg Plowman (Sugen, Inc., Redwood City, USA) Session 3 : Integrin signalling - Mark Ginsberg (The Scripps Research Institute, La Jolla, USA - Walter Birchmeier (Max-Delbück-Center for Molecular Medicine, Berlin, Germany) - John Collard (The Netherlands Cancer Institute, Amsterdam, The Netherlands) Session 4 : Signal transduction in Health and disease - Lorenz Poellinger (Karolinska Institute, Stockholm, Sweden) - Simon L. Goodman (Merck KgaA, Darmstadt, Germany) - Donald Ogilvie (AstraZeneca Pharmaceuticals, Macclesfield, United Kingdom) - Peter Traxler (Novartis Pharmaceuticals, Basel, Switzerland) Session 5 : Signal Transduction and Inflammation - Bart Staels (Institut Pasteur, Lille, France) - Alain Israel (URA CNRS 1773, Institut Pasteur, Paris, France) - Guy Haegman (Flanders Interuniversity Institute for Biotechnology , Ghent, Belgium) Session 6 : Signaling pathways - Mathieu Bollen (Katholieke Universiteit Leuven, Leuven, Belgium) Session 7 : Nutrients regulated gene expression - Axel Kahn (Institut Cochin de Génétique Moléculaire, Paris, France) - Claude Forest (INSERM Unit 530, Meudon, France) - Barath Aggarwal (The University of Texas M. D. Anderson Cancer Center, Houston, USA) Session 8 : Apoptosis pathways I - Moshe Oren (The Weizmann Institute of Science, Rehovot, Israel) - Guido Kroemer (CNRS, UPR 420, Villejuif, France) - Suzanne Cory (The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia) - Peter Krammer (German Cancer Research Center, Heidelberg, Germany) Session 9 : Apoptosis pathways II - Vishva M. Dixit (Genentech Inc., South San Francisco, USA) - Jurg Tschopp (University of Lausanne, Epalinges, Switzerland) - Martin JS Dyer (Institute of Cancer Research, Sutton, United Kingdom) - Vincent Bours (Université de Liège, Belgium) Session 10 : Cell cycle control - Alvaro Puga (University of Cincinnati Medical Center, Cincinnati, USA) - Charles J. Sherr (St. Jude Children's Research Hospital, Memphis, USA) - Tony Hunter (The Salk Institute for Biological Studies, San Diego, USA) Session 11 : G proteins - Johannes L. Bos (Utrecht University, Utrecht, The Netherlands) - Pierre Chardin (IPMC-CNRS UPR 411, Sophia-Antipolis, France) - Alan Hall (University College London, United Kingdom) Session 12 : Kinases - Dario Alessi (University of Dundee, Dundee DD1 5EH, United Kingdom) - Julian Downward (Imperial Cancer Research Fund, London, United Kingdom) - Roger J. Davis (Department of Biochemistry and Molecular Biology, Worcester, USA) - Tony Kong (College of Pharmacy, Chicago, USA) - Jacques Pousségur (Université de Nice, Nice, France) Session 13 : Transcription factor paradigms - Michael Karin (University of California San Diego, La Jolla, USA) - Dominique Stéhelin (CNRS IFR3, Lille, France) - Stuart Orkin (Children's Hospital, Boston, USA) - James Darnell (Memorial Sloan-Kettering Cancer Center, New York, USA) - Gregg L. Semenza (The Johns Hopkins University School of Medicine, Baltimore, USA Session 14 : Translational control - Marylin Kozak (Department of Biochemistry, Piscataway, USA) - Mathias Hentze (European Molecular Biology Laboratory, Heidelberg, Germany - Simon Morley (University of Sussex, Brighton, United Kingdom) |
|||||||||||||||
Deadline for Abstracts: | December 30, 2001 | |||||||||||||||
Registration: | Contact : Marc DIEDERICH RSL/Centre Universitaire de Luxembourg 162A avenue de la Faiencerie L-1511 Luxembourg (Luxembourg) Phone : + 352 46 66 44 434 Fax : + 352 46 66 44 438 Email : diederic@cu.lu |
|||||||||||||||
E-mail: | diederic@cu.lu | |||||||||||||||
Posted by: | Marc Diederich | |||||||||||||||
Host: | ggt.labext.cu.lu | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |